Clinical Trial Detail

NCT ID NCT01983969
Title Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements no
Sponsors M.D. Anderson Cancer Center
Indications

non-Hodgkin lymphoma

Hodgkin's lymphoma

Therapies

Rituximab

Dexamethasone

Busulfan + Melphalan

Azacitidine + Gemcitabine + vorinostat

Age Groups: adult

No variant requirements are available.